Skip to content

Study · Animal study (in vivo) · rat · 1996

1 result

[The neuromediator mechanism of the additive action of the delta sleep-inducing peptide in experimental audiogenic epilepsy caused by hypokinesia].

Mendzheritskiĭ AM, Uskova NI, Lysenko AV, Revinskiĭ IuV

Eksperimental'naia i klinicheskaia farmakologiia1 Jan 1996Cited by 1 (Europe PMC)

PMID8704643 (opens in a new tab)PepBankPUB-08704643

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats under hypokinetic stress, a single intraperitoneal injection of delta sleep-inducing peptide prevented the development of spontaneous epileptic activity.

    In plain wordsIn rats under stress, one injection of delta sleep-inducing peptide prevented spontaneous epileptic activity.

    Outcome
    DecreaseSpontaneous epileptic activity under hypokinetic stress
    Study

    ratn: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    12 microns/100 g body weigh · intraperitoneal · single injectionAs given in this study (rat).

    Source sentences

    Summary
    It was found, that a single intraperitoneal DSIP injection (12 microns/100 g body weigh, 1 h before placing the animals into the stress condition) prevented spontaneous epileptic activity development due to creation of optimal ratio between monoamines in brain structures.
    1 context sentence
    Summary · context
    The DSIP influence on the rat cortex, thalamic and hypothalamic adrenaline, noradrenaline, DOPA, dopamine and serotonin level under normal, hypokinetic stress condition (1 h in duration) and experimental audiogenic epilepsy was studied.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.